Photodynamic therapy (PDT) is a treatment that uses special drugs, called photosensitizes (PS), along with light to kill cancer cells. The distribution of anticancer drugs is an important factor in the success of treatment. The distribution of molecules into the tumor is governed by at least three phenomena: the extravasation from the blood vessels, diffusion through the extravascular tissue and interaction with intracellular targets within the tumor environment. In the present study we used multicellular spheroids to investigate the modification of intratumoral transport of PS via complexation with cyclodextrins.
Multicellular spheroids are spherical aggregates of tumor, which reflect many properties of solid tumors, such as tight junctions between epithelial cells, gradients of nutrient concentrations and cell proliferation from the exterior to the center. By incubating spheroids in a medium that contains an anticancer drug it is possible to examine the kinetics of drug penetration in tumor tissue.
The photosensitizer used in the study is 5,10,15,20-tetra(m-hydroxyphenyl)chlorin (mTHPC). It is one of the most potent second-generation clinically approved photosensitizer [1]. The main limitation of its application in PDT is a low water-solubility. To prevent mTHPC aggregation several special formulations, such as liposomes, polymer solutions and bioconjugates were designed. An application of specialized pharmacological formulations supposes a development of new experimental techniques to control photosensitizer distribution in biological media. Cyclic oligosaccharides, cyclodextrins, are also considered as perspective formulation for tetrapyrrolic photosensitizers.
Cyclodextrins (CDs) are macrocyclic oligosaccharides that combine a hydrophobic nano-sized cavity with a hydrophilic surface. The cavity enables the partial or total incorporation of lipophilic molecules. Cyclodextrins as carriers of various drug molecules can be vehicles of photosensitizers (PS) via complexation [2].
In the present study we have shown, that effect of cyclodextrins on spheroids strongly depends on concentration and type of CD. Low concentrations of CDs result in an increase of mTHPC accumulation in spheroids with a maximal uptake at $4.4 \mu M$ for Methyl-$\beta$-cyclodextrin and $88.2 \mu M$ for 2-Hydroxypropyl-$\beta$-cyclodextrin. Further increase in CDs concentrations is accompanied by a gradual decrease of mTHPC uptake. Another observation is related to the increased mTHPC penetration depth into the tumor spheroids in the presence of CD. Microscopic analysis demonstrated that the presence of CDs results in significant changes of the distribution profiles of mTHPC in spheroids.
We suggest that CDs increase a diffusion rate of mTHPC between biological transporters and cellular targets at the low concentrations (causing less than 50% binding of CD to mTHPC). At the same time, higher CDs concentrations that provide almost complete binding of mTHPC molecules inhibit the accumulation of mTHPC in spheroids.
The data obtained confirm the interest of CDs in mTHPC-PDT.